Rare disease therapeutics with Jack Borrok of Amgen
Nov
7
2024
Nov
7
2024
Description
Jack Borrok, Ph.D., is the senior director of Amgen and will discuss “Rare disease therapeutics.” Borrok is a postdoctoral alumnus of the Georgiou lab.
This is one talk in a series from Texas Biologics this fall covering cutting-edge technology developments across a range of research fields, from mRNA drug discovery to genetic engineering technologies for de-extinction to biologics design and engineering. Their speakers will include experts from Amgen and Regeneron.
Location
NHB 1.720
Share
Other Events in This Series
Nov
19
2024
Cell medicines with Mark Pogson of Regeneron
Texas Biologics presents industry experts who are leading biotech and biologic therapy R&D and commercialization.
9:30 am – 11:00 am • In Person
Speaker(s): Mark Pogson
Feb
13
2025
CMC in the Therapeutic Development Process with Olga Paley of Takeda
Texas Biologics presents industry experts who are leading biotech and biologic therapy R&D and commercialization.
11:00 am – 12:00 pm • In Person
Speaker(s): Olga Paley